Mesa Laboratories, Inc.
MLAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $21 | $27 | $31 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $40 | $39 | $42 | $39 |
| Inventory | $28 | $28 | $25 | $28 |
| Other Curr. Assets | $9 | $10 | $8 | $13 |
| Total Curr. Assets | $97 | $98 | $103 | $111 |
| Property Plant & Equip (Net) | $32 | $32 | $32 | $32 |
| Goodwill | $188 | $188 | $182 | $177 |
| Intangibles | $23 | $97 | $97 | $98 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $1 | $1 | $1 | $1 |
| Other NC Assets | $88 | $19 | $18 | $18 |
| Total NC Assets | $333 | $337 | $331 | $326 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $430 | $436 | $433 | $437 |
| Liabilities | – | – | – | – |
| Payables | $5 | $6 | $6 | $4 |
| Short-Term Debt | $5 | $105 | $105 | $104 |
| Tax Payable | $0 | $12 | $11 | $9 |
| Deferred Revenue | $14 | $15 | $15 | $15 |
| Other Curr. Liab. | $24 | $11 | $28 | $24 |
| Total Curr. Liab. | $48 | $149 | $164 | $156 |
| LT Debt | $106 | $92 | $77 | $107 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $22 | $22 | $20 | $19 |
| Other NC Liab. | $76 | $0 | $12 | $0 |
| Total NC Liab. | $204 | $114 | $110 | $126 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $16 | $4 | $16 |
| Total Liabilities | $252 | $263 | $274 | $282 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $365 | $361 | $359 | $353 |
| Retained Earnings | -$183 | -$185 | -$189 | -$181 |
| AOCI | -$3 | -$4 | -$10 | -$17 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $178 | $172 | $160 | $155 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $430 | $436 | $433 | $437 |
| Net Debt | $90 | $176 | $154 | $181 |